Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro
Hualong Xiong(Xiamen University), Ningshao Xia(Xiamen University)
Cited by 32
Related Papers
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k
Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant
|Emerging infectious diseases|2018|268
Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019
|SSRN Electronic Journal|2020|222
Recent Progress on the Versatility of Virus-Like Particles
|Vaccines|2020|171